
        <!DOCTYPE html>
        <html>
        <head>
            <title>Syndax Pharmaceuticals Inc. (SNDX) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Syndax Pharmaceuticals Inc. (SNDX)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">‚Üê Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">15</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">6</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">3</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.16</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=46a5f79b83a38086d32dc1c4ddb74ae3fd22211ee14d581bf69c8cfcb5c75a3d" target="_blank" rel="noopener noreferrer">Analysts Just Made A Dazzling Upgrade To Their Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Forecasts</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.87
                                </span>
                            </div>
                            <div class="article-summary">NasdaqGS:SNDX 1 Year Share Price vs Fair Value Explore Syndax Pharmaceuticals's Fair Values from the Community and......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=dcf20f1064ea1a93996092167fd530b28b5724b3b75d9a27aadbaedab157cc0f" target="_blank" rel="noopener noreferrer">Syndax Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.87
                                </span>
                            </div>
                            <div class="article-summary">NasdaqGS:SNDX 1 Year Share Price vs Fair Value Explore Syndax Pharmaceuticals's Fair Values from the Community and......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=80c3fc3048f4342e32b0a2107101fcd086064685ff987d1374738ef13bb2b2ed" target="_blank" rel="noopener noreferrer">Citi ups Syndax target, opens ‚Äòupside catalyst watch‚Äô</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Citi analyst Yigal Nochomovitz raised the firm‚Äôs price target on Syndax (SNDX) to $51 from $46 and keeps a Buy rating on the shares. The firm also added a positive ‚Äúupside catalyst watch‚Äù on Syndax ah...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8e590dca07fcaa22eb1cc8af63336f4adfa9885f98998639fada4e37f99b2db3" target="_blank" rel="noopener noreferrer">Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on August 1,...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9f7b8cd70e76a549f48edeff6e171b89d9cb66c0a54741f07c639bfb7b853a7c" target="_blank" rel="noopener noreferrer">Syndax Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call Presentation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The following slide deck was published by Syndax Pharmaceuticals, Inc....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=84f629d76d31981e2e54a422f7ec1af293ffd28134967fe900be6e2388539678" target="_blank" rel="noopener noreferrer">Syndax Pharmaceuticals, Inc. (SNDX) Q2 2025 Earnings Call Transcript</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ETCompany ParticipantsKeith Alan Goldan - CFO, Treasurer......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e12e70a1ac0365fdeb6f15c8db5713176fb396f861969cb2ca162f027fec6088" target="_blank" rel="noopener noreferrer">Syndax Pharmaceuticals: The Story Brightens</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Syndax Pharmaceuticals just delivered strong second quarter results, beating expectations. Click here to find out why SNDX stock is a Hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=af5d79ccf175073627ee4b86b3e158b9c182a36665768db90680b050bf5ae282" target="_blank" rel="noopener noreferrer">Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.49
                                </span>
                            </div>
                            <div class="article-summary">‚Äì $28.6 million of Revuforj¬Æ (revumenib) net revenue, representing 43% growth over 1Q25 ‚Äì ‚Äì $36.2 million of Niktimvo‚Ñ¢ (axatilimab-csfr) net revenue reported by Incyte in first full quarter of launch;...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6fe08d9699462e8d276fb725117a43732e3940d895605a8a3d80baffea159e01" target="_blank" rel="noopener noreferrer">Syndax: Q2 Earnings Snapshot</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.76
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK (AP) ‚Äî Syndax Pharmaceuticals Inc. SNDX) on Monday reported a loss of $71.8 million in its second quarter. On a per-share basis, the New York-based company said it had a loss of 83 cents....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ea526356640bf522c79763dbf50df83f37c6fbe1a7cf546956bdcad93ef5f68a" target="_blank" rel="noopener noreferrer">Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">Syndax (SNDX) delivered earnings and revenue surprises of +17.00% and +30.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e" target="_blank" rel="noopener noreferrer">Franklin Biotechnology Discovery Fund Q2 2025 Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Franklin Templeton√¢¬Ä¬ôs Biotechnology Discovery Fund sees long-term potential despite Q2 losses. Explore how innovation and AI are shaping its outlook....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cc008efb9f9688d5757bb9c3afe270c4b5e524cf7a0d50c44dcd355b3ea79d4f" target="_blank" rel="noopener noreferrer">Wall Street Analysts Predict a 237.83% Upside in Syndax (SNDX): Here's  What You Should Know</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">The average of price targets set by Wall Street analysts indicates a potential upside of 237.8% in Syndax (SNDX). While the effectiveness of this highly sought-after metric is questionable, the positi...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b2ec1feb092a470d7218328664dfc551444d0a8d94ccdf0ff3aebe8e75b11ecb" target="_blank" rel="noopener noreferrer">Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.38
                                </span>
                            </div>
                            <div class="article-summary">Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=23504f04e08fe3d576813ef30f99753192074769655c719bdf94d8bca084135b" target="_blank" rel="noopener noreferrer">All You Need to Know About Syndax (SNDX) Rating Upgrade to Buy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Syndax (SNDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5d92e9dca2bde0be15a7ccb1694dba10637761da7184457d2f8c589db7fd5ba9" target="_blank" rel="noopener noreferrer">Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will repo...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        